Vimarsana
Biggest News Aggregation in the World

Board Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Board Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Board Number Today - Breaking & Trending Today

Onera Health: Onera Presents New Clinical Data featuring the Innovative Onera STS at SLEEP 2024 - Vimarsana News

Onera Health: Onera Presents New Clinical Data featuring the Innovative Onera STS at SLEEP 2024

Onera Health exhibits and presents the latest data in poster abstracts at SLEEP 2024, the Associated Professional Sleep Societies, LLC (APSS) annual meeting. Onera Health, a leader in transforming

Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024 - Vimarsana News

Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024

- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -

Kinomica Ltd.: Kinomica, King's College London and King's College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting - Vimarsana News

Kinomica Ltd.: Kinomica, King's College London and King's College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting

Investigators will present study highlighting a phosphoproteomic diagnostic for patient stratification of first line systemic hepatocellular carcinoma therapy LONDON, May 28, 2024 /PRNewswire/

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 - Vimarsana News

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024 - Vimarsana News

GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024

YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical